Follow
Adriano Venditti
Adriano Venditti
Professore Ordinario di Ematologia
Verified email at uniroma2.it
Title
Cited by
Cited by
Year
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
New England Journal of Medicine 369 (2), 111-121, 2013
1633*2013
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ...
Blood, The Journal of the American Society of Hematology 131 (12), 1275-1291, 2018
10432018
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
F Passamonti, C Cattaneo, L Arcaini, R Bruna, M Cavo, F Merli, ...
The Lancet Haematology 7 (10), e737-e745, 2020
5382020
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML) Presented in part at the 42nd annual meeting of the American …
G Del Poeta, A Venditti, MI Del Principe, L Maurillo, F Buccisano, ...
Blood, The Journal of the American Society of Hematology 101 (6), 2125-2131, 2003
4552003
Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management
R Stasi, ML Evangelista, E Stipa, F Buccisano, A Venditti, S Amadori
Thrombosis and haemostasis 99 (01), 4-13, 2008
4142008
Clinical significance of CD38 expression in chronic lymphocytic leukemia
G Del Poeta, L Maurillo, A Venditti, F Buccisano, AM Epiceno, G Capelli, ...
Blood, The Journal of the American Society of Hematology 98 (9), 2633-2639, 2001
3932001
Gemtuzumab ozogamicin versus best supportive care in older patients with newly diagnosed acute myeloid leukemia unsuitable for intensive chemotherapy: results of the randomized …
S Amadori, S Suciu, D Selleslag, F Aversa, G Gaidano, M Musso, ...
Journal of Clinical Oncology 34, 2016
3622016
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia: Presented in part at the 41st Annual Meeting of the American Society …
A Venditti, F Buccisano, G Del Poeta, L Maurillo, A Tamburini, C Cox, ...
Blood, The Journal of the American Society of Hematology 96 (12), 3948-3952, 2000
3452000
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F Buccisano, L Maurillo, MI Del Principe, G Del Poeta, G Sconocchia, ...
Blood, The Journal of the American Society of Hematology 119 (2), 332-341, 2012
3342012
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
M Heuser, SD Freeman, GJ Ossenkoppele, F Buccisano, CS Hourigan, ...
Blood, The Journal of the American Society of Hematology 138 (26), 2753-2767, 2021
3272021
Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia
F Lo-Coco, G Cimino, M Breccia, NI Noguera, D Diverio, E Finolezzi, ...
Blood 104 (7), 1995-1999, 2004
3022004
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia
MI Del Principe, G Del Poeta, F Buccisano, L Maurillo, A Venditti, ...
Blood 108 (3), 853-861, 2006
2412006
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia
L Maurillo, F Buccisano, MI Del Principe, G Del Poeta, A Spagnoli, ...
Journal of clinical oncology 26 (30), 4944-4951, 2008
1952008
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial
R Willemze, S Suciu, GR Meloni, B Labar, JP Marie, CJM Halkes, P Muus, ...
Journal of clinical oncology 32 (3), 219-228, 2014
1852014
Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult …
F Buccisano, L Maurillo, A Spagnoli, MI Del Principe, D Fraboni, ...
Blood, The Journal of the American Society of Hematology 116 (13), 2295-2303, 2010
1772010
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia
G Del Poeta, R Stasi, G Aronica, A Venditti, MC Cox, A Bruno, ...
1731996
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic …
MT Voso, S Fenu, R Latagliata, F Buccisano, A Piciocchi, MA Aloe-Spiriti, ...
J Clin Oncol 31 (21), 2671-2677, 2013
1722013
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia
A Venditti, A Piciocchi, A Candoni, L Melillo, V Calafiore, R Cairoli, ...
Blood, The Journal of the American Society of Hematology 134 (12), 935-945, 2019
1652019
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia
F Buccisano, L Maurillo, V Gattei, G Del Poeta, MI Del Principe, MC Cox, ...
Leukemia 20 (10), 1783-1789, 2006
1652006
Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia
G Cimino, F Lo-Coco, S Fenu, L Travaglini, E Finolezzi, M Mancini, ...
Cancer research 66 (17), 8903-8911, 2006
1552006
The system can't perform the operation now. Try again later.
Articles 1–20